RELMADA THERAPEUTICS, INC. Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option of -$26.11 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Notes
us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption · last filed 2014-11-07
- RELMADA THERAPEUTICS, INC. increase (decrease) in fair value adjustments on other assets (liabilities) carried at fair value under fair value option for the quarter ending 2014-09-30 was -$26.11M.
- RELMADA THERAPEUTICS, INC. increase (decrease) in fair value adjustments on other assets (liabilities) carried at fair value under fair value option for the quarter ending 2013-09-30 was -$1.02M.
| Period end | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option 3 month |
|---|---|
| 2014-09-30 | -$26.11M 10-Q · filed 2014-11-07 |
| 2013-09-30 | -$1.02M 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |